The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery
ConditionCataract Surgery Anesthesia
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age60+
SponsorAl-Azhar University
About this trial
Cataract surgery is routinely performed with anesthesia care, whereas anesthesia care for other elective, low-risk, outpatient procedures is applied more selectively. We hypothesize that sublingual melatonin will provide superior anxiolysis and sedation while maintaining a high safety profile and minimizing hemodynamic disturbances.
Eligibility criteria
Qualifiers
• Age ≥ 60 years
American Society of Anesthesiologists (ASA) physical status I-III
Scheduled for unilateral cataract surgery under local anesthesia
Ability to understand and complete study-related questionnaires
Disqualifiers
• Known allergy or hypersensitivity to melatonin
Chronic use of sedatives, hypnotics, or anxiolytics
History of sleep disorders or psychiatric illness
Visual or hearing impairment that would hinder communication
Trial design
Treatments tested in this trial
- Sublingual Melatonin
- Sublingual Placebo
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov